52
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Patterns of graft and patient survival following renal transplantation and evaluation of serum creatinine as a predictor of survival: a review of data collected from one clinical centre over 34 years

, , , &
Pages 1793-1800 | Accepted 23 Sep 2005, Published online: 06 Oct 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Siavash Rezapour, Aliasghar Yarmohammadi & Mahmoud Tavakkoli. (2017) One-year survival rate of renal transplant: factors influencing the outcome. Transplant Research and Risk Management 9, pages 49-56.
Read now
Olaf Boenisch & Anil Chandraker. (2008) Predictive biomarkers of renal allograft failure. Expert Opinion on Medical Diagnostics 2:11, pages 1279-1290.
Read now

Articles from other publishers (6)

Towhid Belal, Tanvir Ahmed Chowdhury, Shamim Hossain, Afzalul Haque, Nazim Uddin Arif & Kamrul Islam. (2021) A renal transplantation programme in Bangladesh during the COVID-19 pandemic. Journal of Kidney Care 6:4, pages 174-182.
Crossref
. Experimental and Clinical Transplantation 14:1.
Crossref
YI-TIAN TING, P TOBY COATES, ROBERT J WALKER & ALEXANDER D MCLELLAN. (2012) Urinary tubular biomarkers as potential early predictors of renal allograft rejection. Nephrology 17:1, pages 11-16.
Crossref
Bj?rn Nashan. (2009) Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?. Transplantation Reviews 23:1, pages 47-52.
Crossref
Phil McEwan, Simon Dixon, Keshwar Baboolal, Pete Conway & Craig J Currie. (2006) Evaluation of the Cost Effectiveness of Sirolimus versus Tacrolimus for Immunosuppression Following Renal Transplantation in the UK. PharmacoEconomics 24:1, pages 67-79.
Crossref
Phil McEwan, Keshwar Baboolal, Pete Conway & Craig J. Currie. (2005) Evaluation of the cost-effectiveness of Sirolimus versus cyclosporin for immunosuppression after renal transplantation in the United Kingdom. Clinical Therapeutics 27:11, pages 1834-1846.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.